pharmaceutical daily

PRINCETON, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BMY&src=ctag" target="_blank"gt;$BMYlt;/agt; lt;a href="https://twitter.com/hashtag/BMS?src=hash" target="_blank"gt;#BMSlt;/agt;–Bristol-Myers Squibb Company (NYSE: BMY) today announced the Phase 3 CheckMate -498 trial…

DUBLIN–(BUSINESS WIRE)–The “Traveler’s Diarrhea – Market Insights, Epidemiology and Market Forecast – 2028” drug pipelines has been added to ResearchAndMarkets.com’s…

‒ Q1 2019 Net Revenue of $446 Million; GAAP Loss per share of $0.37; Combined Adjusted Diluted EPS(1) of $0.14…

New Collaboration with Seattle Children’s Research Institute Targets New Immunotherapy Approaches to Acute Myeloid Leukemia Phase 1/2 Study for Merkel…

Gross margin (reported) improved 190 basis points to 53.0 percent of revenue Earnings per share (EPS) was $0.09 (reported), or…

DUBLIN–(BUSINESS WIRE)–The “Duchenne Muscular Dystrophy – Market Insights, Epidemiology and Market Forecast – 2028” drug pipelines has been added to…

DUBLIN–(BUSINESS WIRE)–The “Acromegaly – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive insights…